Recent JAZZ News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/08/2024 10:55:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 12:32:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2024 09:06:15 PM
- Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results • PR Newswire (US) • 11/06/2024 09:05:00 PM
- Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia • PR Newswire (US) • 10/31/2024 08:05:00 PM
- Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024 • PR Newswire (US) • 10/23/2024 08:15:00 PM
- Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024 • PR Newswire (US) • 10/23/2024 08:15:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/21/2024 08:11:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 08:13:42 PM
- PharmaMar Announces Positive and Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer • PR Newswire (US) • 10/15/2024 02:31:00 PM
- Jazz Pharmaceuticals Announces Statistically Significant Overall Survival and Progression-Free Survival Results for Zepzelca® (lurbinectedin) and Atezolizumab Combination in First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer • PR Newswire (US) • 10/15/2024 11:30:00 AM
- Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 • PR Newswire (US) • 09/16/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 03:38:33 PM
- Jazz Pharmaceuticals to Present Advancements in Solid Tumor Oncology Research at ESMO 2024 • PR Newswire (US) • 09/09/2024 11:58:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:09:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/05/2024 11:50:34 PM
- Jazz Pharmaceuticals to Present New Data Demonstrating Improved Epilepsy Outcomes with Epidiolex®/Epidyolex® (cannabidiol) at the European Epilepsy Congress 2024 • PR Newswire (US) • 09/05/2024 11:30:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:12:00 AM
- Jazz Pharmaceuticals Announces Pricing of Private Offering of $850 Million of 3.125% Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/04/2024 04:00:00 AM
- Jazz Pharmaceuticals Announces Private Offering of $850 Million of Exchangeable Senior Notes due 2030 and Concurrent Ordinary Share Repurchases • PR Newswire (US) • 09/03/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 06:27:01 PM
- Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies • PR Newswire (US) • 08/22/2024 08:05:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Jazz Pharmaceuticals to Participate in Upcoming September Investor Conferences • PR Newswire (US) • 08/21/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:45:01 PM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM